Logo image of ALBPK.PA

BROADPEAK (ALBPK.PA) Stock Fundamental Analysis

EPA:ALBPK - FR001400AJZ7 - Common Stock

1.96 EUR
+0.09 (+4.81%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

2

ALBPK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 26 industry peers in the Communications Equipment industry. Both the profitability and financial health of ALBPK have multiple concerns. ALBPK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALBPK had negative earnings in the past year.
In the past year ALBPK had a positive cash flow from operations.
In multiple years ALBPK reported negative net income over the last 5 years.
In multiple years ALBPK reported negative operating cash flow during the last 5 years.
ALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBPK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With a Return On Assets value of -7.91%, ALBPK perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
ALBPK has a worse Return On Equity (-19.96%) than 61.54% of its industry peers.
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBPK.PA Yearly ROA, ROE, ROICALBPK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ALBPK has a better Gross Margin (100.47%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALBPK has grown nicely.
ALBPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALBPK.PA Yearly Profit, Operating, Gross MarginsALBPK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

3

2. Health

2.1 Basic Checks

ALBPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBPK has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ALBPK has been reduced compared to a year ago.
ALBPK.PA Yearly Shares OutstandingALBPK.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBPK.PA Yearly Total Debt VS Total AssetsALBPK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.86, we must say that ALBPK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.86, ALBPK is doing worse than 61.54% of the companies in the same industry.
ALBPK has a debt to FCF ratio of 16.11. This is a negative value and a sign of low solvency as ALBPK would need 16.11 years to pay back of all of its debts.
The Debt to FCF ratio of ALBPK (16.11) is worse than 61.54% of its industry peers.
ALBPK has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.44, ALBPK perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Altman-Z 0.86
ROIC/WACCN/A
WACC6.55%
ALBPK.PA Yearly LT Debt VS Equity VS FCFALBPK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALBPK has a Current Ratio of 1.29. This is a normal value and indicates that ALBPK is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALBPK (1.29) is worse than 76.92% of its industry peers.
A Quick Ratio of 1.29 indicates that ALBPK should not have too much problems paying its short term obligations.
ALBPK has a Quick ratio (1.29) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
ALBPK.PA Yearly Current Assets VS Current LiabilitesALBPK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.09% over the past year.
The Revenue has been growing slightly by 0.87% in the past year.
The Revenue has been growing slightly by 5.93% on average over the past years.
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%

3.2 Future

The Earnings Per Share is expected to grow by 43.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALBPK will show a quite strong growth in Revenue. The Revenue will grow by 8.91% on average per year.
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALBPK.PA Yearly Revenue VS EstimatesALBPK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALBPK.PA Yearly EPS VS EstimatesALBPK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBPK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALBPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBPK.PA Price Earnings VS Forward Price EarningsALBPK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as ALBPK.
Industry RankSector Rank
P/FCF 36.09
EV/EBITDA N/A
ALBPK.PA Per share dataALBPK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALBPK's earnings are expected to grow with 43.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.91%
EPS Next 3Y43.18%

0

5. Dividend

5.1 Amount

ALBPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BROADPEAK

EPA:ALBPK (9/3/2025, 7:00:00 PM)

1.96

+0.09 (+4.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.15%
Inst Owner ChangeN/A
Ins Owners49.73%
Ins Owner ChangeN/A
Market Cap24.58M
Analysts86
Price Target2.81 (43.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10%
PT rev (3m)10%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-275%
EPS NY rev (3m)-275%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)3.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF 36.09
P/OCF 2.41
P/B 1.22
P/tB 9.18
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.05
FCFY2.77%
OCF(TTM)0.81
OCFY41.5%
SpS3.14
BVpS1.61
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.91%
ROE -19.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100.48%
FCFM 1.73%
ROA(3y)-4.48%
ROA(5y)0.39%
ROE(3y)-10.87%
ROE(5y)10.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 16.11
Debt/EBITDA N/A
Cap/Depr 175.48%
Cap/Sales 24.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.86
F-Score6
WACC6.55%
ROIC/WACCN/A
Cap/Depr(3y)283.73%
Cap/Depr(5y)362.99%
Cap/Sales(3y)24.24%
Cap/Sales(5y)18.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y75.81%
EPS Next 2Y45.91%
EPS Next 3Y43.18%
EPS Next 5YN/A
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.93%
Revenue growth 5YN/A
Sales Q2Q%5.88%
Revenue Next Year11.68%
Revenue Next 2Y8.99%
Revenue Next 3Y8.91%
Revenue Next 5YN/A
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year164.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y371.81%
OCF growth 3Y167.99%
OCF growth 5YN/A